You are here: Home » News-CM » Companies » Results
Business Standard

Genomic Valley Biotech standalone net profit rises 12.50% in the December 2019 quarter

Capital Market 

Sales decline 30.77% to Rs 0.18 crore

Net profit of Genomic Valley Biotech rose 12.50% to Rs 0.09 crore in the quarter ended December 2019 as against Rs 0.08 crore during the previous quarter ended December 2018. Sales declined 30.77% to Rs 0.18 crore in the quarter ended December 2019 as against Rs 0.26 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales0.180.26 -31 OPM %72.2250.00 -PBDT0.140.13 8 PBT0.090.08 13 NP0.090.08 13

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, February 14 2020. 16:29 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU